Angiotensin 1 – 7 stimulation of platelet recovery

Bibliography

• Vadhan-Raj S. Management of chemotherapy-induced thrombocyto penia: current status of thrombopoietic agents. Semin Hematol 2009;46(1Suppl 2):S26-32
   PubMedGoogle Scholar
• Li X, Slayton WB. Molecular mechanisms of platelet and stem cell rebound after 5-fluorouracil treatment. Exp hematol 2013;41(7):635-45
   PubMed Web of Science ®Google Scholar
• Peterson DE, Keefe DM, Sonis ST. New frontiers in mucositis. In: Govindan R, editor, 2012 ASCO educational book. Am Soc Clin Oncol, Alexandria, VA, USA; 2012. p. 545-51
   Google Scholar
• Waselenko JK, MacVittie TJ, Blakely WF, et al. Medical management of the acute radiation syndrome: recommendations of the strategic national stockpile radiation working group. Ann Intern Med 2004;140(12):1037-51
   PubMed Web of Science ®Google Scholar
• Stickney DR, Dowding C, Authier S, et al. 5-androstenediol improves survival in clinically unsupported rhesus monkeys with radiation-induced myelosuppression. Int Immunopharmacol 2007;7(4):500-5
   PubMed Web of Science ®Google Scholar
• Kaushansky K. The thrombocytopenia of cancer: prospects for effective cytokine therapy. Hematol Oncol Clin North Am 1996;10(2):431-55
   PubMed Web of Science ®Google Scholar
• Vamvakas EC. Commentary: relative safety of pooled whole blood-derived versus single donor (apheresis) platelets in the united states: a systematic review of disparate risks. Transfusion 2009;49(12):2743-58
   PubMed Web of Science ®Google Scholar
• Elting LS, Cantor SB, Martin CG, et al. Cost of chemotherapy‐induced thrombocytopenia among patients with lymphoma or solid tumors. Cancer 2003;97(6):1541-50
   PubMed Web of Science ®Google Scholar
• Pedini F, Venneri MA, Zeuner A. Hematopoietic stem/progenitor cells: response to chemotherapy. Stem cells and cancer stem cells. Volume 6. Springer, Netherlands; 2012. p. 333-44
   Google Scholar
• Machlus KR, Italiano JE. The incredible journey: from megakaryocyte development to platelet formation. J Cell Biol 2013;201(6):785-96
   PubMed Web of Science ®Google Scholar
• Kashiwakura I, Kuwabara M, Inanami O, et al. Radiation sensitivity of megakaryocyte colony-forming cells in human placental and umbilical cord blood. Radiat Res 2000;153(2):144-52
   PubMed Web of Science ®Google Scholar
• Zeuner A, Signore M, Martinetti D, et al. Chemotherapy-induced thrombocytopenia derives from the selective death of megakaryocyte progenitors and can be rescued by stem cell factor. Cancer Res 2007;67(10):4767-73
   PubMed Web of Science ®Google Scholar
• Klinger MH. Platelets and inflammation. Anat Embryol 1997;196(1):1-11
   PubMedGoogle Scholar
• Weyrich AS, Lindemann S, Zimmerman GA. The evolving role of platelets in inflammation. J Thromb Haemost 2003;1(9):1897-905
   PubMed Web of Science ®Google Scholar
• Gurtner GC, Werner S, Barrandon Y, Longaker MT. Wound repair and regeneration. Nature 2008;453(7193):314-21
   PubMed Web of Science ®Google Scholar
• Lacci KM, Dardik A. Platelet-rich plasma: support for its use in wound healing. Yale J Biol Med 2010;83(1):1
   PubMedGoogle Scholar
• Davies WA, Ackerman VP, Nelson DS. Mechanism for nonspecific immunity of Listeria monocytogenes in rats mediated by platelets and the clotting system. Infect Immun 1981;33(2):477-81
   PubMed Web of Science ®Google Scholar
• Diacovo TG, Catalina MD, Siegelman MH, von Andrian UH. Circulating activated platelets reconstitute lymphocyte homing and immunity in L-selectin–deficient mice. J Exp Med 1998;187(2):197-204
   PubMed Web of Science ®Google Scholar
• Akashi K, Kondo M, Weissman IL. Two distinct pathways of positive selection for thymocytes. Proc Natl Acad Sci USA 1998;95(5):2486-91
   PubMed Web of Science ®Google Scholar
• Akashi K, Traver D, Miyamoto T, Weissman IL. A clonogenic common myeloid progenitor that gives rise to all myeloid lineages. Nature 2000;404(6774):193-7
   PubMed Web of Science ®Google Scholar
• von Hundelshausen P, Petersen F, Brandt E. Platelet-derived chemokines in vascular biology. Thromb Haemost 2007;97(5):704-13
   PubMed Web of Science ®Google Scholar
• Gawaz M, Vogel S. Platelets in tissue repair: control of apoptosis and interactions with regenerative cells. Blood 2013;122(15):2550-4
   PubMed Web of Science ®Google Scholar
• Gnecchi M, Zhang Z, Ni A, Dzau VJ. Paracrine mechanisms in adult stem cell signaling and therapy. Circ Res 2008;103(11):1204-19
   PubMed Web of Science ®Google Scholar
• Jackson EK, Garrison JC. Renin and angiotensin. In: Hardman JG, Limbird LE, Molinoff PB, Ruddpm RW, Gilman AG, editors, Goodman and Gilman's the pharmacological basis of therapeutics. McGraw-Hill, New York; 1996. p. 733-58
   Google Scholar
• Haznedaroglu IC, Öztürk MA. Towards the understanding of the local hematopoietic bone marrow renin-angiotensin system. Int J Biochem Cell Biol 2003;35(6):867-80
   PubMed Web of Science ®Google Scholar
• Strawn WB, Richmond RS, Ann Tallant E, et al. Renin–angiotensin system expression in rat bone marrow haematopoietic and stromal cells. Br J Haematol 2004;126(1):120-6
   PubMed Web of Science ®Google Scholar
• Rodgers KE, diZerega GS. Contribution of the local RAS to hematopoietic function: a novel therapeutic target. Front Endocrinol 2013;4:157
   Google Scholar
• Park TS, Zambidis ET. A role for the renin-angiotensin system in hematopoiesis. Haematologica 2009;94(6):745-7
   PubMed Web of Science ®Google Scholar
• Shen XZ, Bernstein KE. The peptide network regulated by angiotensin converting enzyme (ACE) in hematopoiesis. Cell Cycle 2011;10(9):1363-9
   PubMed Web of Science ®Google Scholar
• Durik M, Pessoa BS, Roks AJ. The renin-angiotensin system, bone marrow and progenitor cells. Clin Sci(Lond) 2012;123(4):205-23
   PubMed Web of Science ®Google Scholar
• Rodgers KE, Espinoza T, Roda N, et al. Accelerated hematopoietic recovery with angiotensin-(1 – 7) after total body radiation. Int J Radiat Biol 2012;88(6):466-76
   PubMed Web of Science ®Google Scholar
• Haznedaroglu IC, Beyazit Y. Local bone marrow renin-angiotensin system in primitive, definitive and neoplastic haematopoiesis. Clin Sci(Lond) 2013;124(5):307-23
   PubMed Web of Science ®Google Scholar
• Passos-Silva DG, Verano-Braga T, Santos RA. Angiotensin-(1 – 7): beyond the cardio-renal actions. Clin Sci (Lond) 2013;124(7):443-56
   PubMed Web of Science ®Google Scholar
• Marusic Vrsalovic M, Dominis M, Jaksic B, Kusec R. Angiotensin I‐converting enzyme is expressed by erythropoietic cells of normal and myeloproliferative bone marrow. Br Haematol 2003;123(3):539-41
   PubMed Web of Science ®Google Scholar
• Sica DA. ACE inhibitors and anemia in congestive heart failure. Congest Heart Fail 2000;6(6):330-2
   PubMedGoogle Scholar
• Naito M, Kawashima A, Akiba T, et al. Effects of an angiotensin II receptor antagonist and angiotensin-converting enzyme inhibitors on burst forming units-erythroid in chronic hemodialysis patients. Am J Nephrol 2003;23(5):287-93
   PubMed Web of Science ®Google Scholar
• Brunton LL, Lazo JS, Parker KL. Renin and angiotensin. In: Jackson E, editor, Goodman, Gilman's the pharmacological basis of therapeutics. 11th edition. McGraw-Hill, New York; 2006. p. 789-821
   Google Scholar
• Santos RA, e Silva ACS, Maric C, et al. Angiotensin-(1 – 7) is an endogenous ligand for the G protein-coupled receptor Mas. Proc Natl Acad Sci USA 2003;100(14):8258-63
   PubMed Web of Science ®Google Scholar
• Bader M, Santos RA, Unger T,
   Google Scholar
• Rodgers K, Xiong S, Felix J, et al. Development of angiotensin (1 – 7) as an agent to accelerate dermal repair. Wound Repair Regen 2001;9(3):238-47
   PubMed Web of Science ®Google Scholar
• Ellefson DD, Espinoza T, Roda N, et al. Synergistic effects of co-administration of angiotensin 1 – 7 and Neupogen on hematopoietic recovery in mice. Cancer Chemother Pharmacol 2004;53(1): 15-24
   PubMed Web of Science ®Google Scholar
• Jadhav SS, Sharma N, Meeks CJ, et al. Effects of combined radiation and burn injury on the renin–angiotensin system. Wound Repair Regen 2013;21(1):131-40
   PubMed Web of Science ®Google Scholar
• Gallinat S, Yu M, Dorst A, et al. Sciatic nerve transection evokes lasting up-regulation of angiotensin AT2 and AT 1receptor mRNA in adult rat dorsal root ganglia and sciatic nerves. Brain Res Mol Brain Res 1998;57(1):111-22
   PubMedGoogle Scholar
• Rodgers KE, Xiong S, Steer R, DiZerega GS. Effect of angiotensin II on hematopoietic progenitor cell proliferation. Stem Cells 2000;18(4):287-94
   PubMed Web of Science ®Google Scholar
• Rodgers KE, Xiong S. Accelerated recovery from irradiation injury by angiotensin peptides. Cancer Chemother Pharmacol 2002;49(5):403-11
   PubMed Web of Science ®Google Scholar
• Rodgers K, Xiong S. Effect of angiotensin II and angiotensin (1 – 7) on hematopoietic recovery after intravenous chemotherapy. Cancer Chemother Pharmacol 2003;51(2):97-106
   PubMed Web of Science ®Google Scholar
• Rodgers KE, Oliver J. Phase I/II dose escalation study of angiotensin 1 – 7 [A (1 – 7)] administered before and after chemotherapy in patients with newly diagnosed breast cancer. Cancer Chemother Pharmacol 2006;57(5):559-68
   PubMed Web of Science ®Google Scholar
• Zambidis ET, Park TS, Yu W, et al. Expression of angiotensin-converting enzyme (CD143) identifies and regulates primitive hemangioblasts derived from human pluripotent stem cells. Blood 2008;112(9):3601-14
   PubMed Web of Science ®Google Scholar
• Heringer-Walther S, Eckert K, Schumacher SM, et al. Angiotensin-(1 – 7) stimulates hematopoietic progenitor cells in vitro and in vivo. Haematologica 2009;94(6):857-60
   PubMed Web of Science ®Google Scholar
• Rodgers KE, Espinoza TB, Roda N, Meeks CJ. Angiotensin-(1 – 7) synergizes with colony-stimulating factors in hematopoietic recovery. Cancer Chemother Pharmacol 2013;72(6):1235-45
   PubMed Web of Science ®Google Scholar
• Pham H, Schwartz BM, Delmore JE, et al. Pharmacodynamic stimulation of thrombogenesis by angiotensin (1 – 7) in recurrent ovarian cancer patients receiving gemcitabine and platinum-based chemotherapy. Cancer Chemother Pharmacol 2013;71(4):965-72
   PubMed Web of Science ®Google Scholar